Delek Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Delek Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$57.4M	Buy	6,367,642 +1,230,259	+24%	+$14.8M	2.22%	4
2019 Q1	$80.2M	Buy	5,137,383 +1,752,361	+52%	+$30.9M	3.33%	1
2018 Q4	$53.6M	Buy	3,385,022 +1,767,313	+109%	+$36.2M	2.45%	3
2018 Q3	$34.6M	Buy	1,617,709 +29,000	+2%	+$673K	1.45%	11
2018 Q2	$38.6M	Sell	1,588,709 -154,600	-9%	-$3.15M	1.66%	8
2018 Q1	$29.8M	Sell	1,743,309 -296,100	-15%	-$5.78M	1.53%	10
2017 Q4	$38.6M	Buy	+2,039,409	New	+$30.7M	2.07%	7

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Delek Group's TEVA Position: Q2 2019 in Review

Delek Group increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 24% in Q2 2019, buying an estimated $14.8M and bringing the position to 6,367,642 shares worth $57.4M. The position accounts for 2.22% of the portfolio, ranked #4.

Delek Group first reported a position in TEVA in Q4 2017 and has held it in 7 quarters since. The position peaked at $80.2M in Q1 2019. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Delek Group held 6,367,642 shares of Teva Pharmaceutical Industries Limited worth $57.4M as of Q2 2019.
Delek Group bought 1,230,259 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $14.8M.
Teva Pharmaceutical Industries Limited made up 2.22% of Delek Group's portfolio in Q2 2019, its #4 holding.
Delek Group first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and has held it in 7 quarters since.
Delek Group's Teva Pharmaceutical Industries Limited position peaked at $80.2M in Q1 2019.
452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.